United States· US:60429-918_288c1f6b-3779-3b65-e063-6394a90ae906

Glimepiride

A glimepiride product containing glimepiride, registered in United States by Golden State Medical Supply, Inc.. The same ATC class is registered in 17 of our 19 countries.

ATC A10BB12US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedGlimepirideATCA10BB12REGISTER NO.US:60429-918_288c1f6b…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Glimepiride is registered in 17 of 19 countries.

Countries holding a registration under ATC A10BB12 (glimepiride), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose

Glimepiride · ATC A10BB12

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of glimepiride costs, country by country.

Normalised to the WHO defined daily dose (2 mg), the median price runs from $0.081 in Italy to $0.30 in Switzerland — a ×3.7 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Glimepiride · price per daily dose (2 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.30
  • FR France$0.14
  • IT Italy$0.081
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
GLIMEPIRIDE
Manufacturer
Golden State Medical Supply, Inc.
Country
United States (US)
ATC code
A10BB12
ATC class
Glimepiride
Defined daily dose
2 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    6042991801
    100 TABLET in 1 BOTTLE (60429-918-01)
  • ndc11
    60429-918-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

723 interactions on record for glimepiride.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Glimepiride · interactions on record

723 records

  • 20 severe
  • 448 moderate
  • 47 minor
  • 208 info

Most severe, free to view

  • MiconazoleA07AC01severe
  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate
  • Magnesium hydroxideA02AA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glimepiride in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glimepiride products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Glimepirid 1a Pharma, Glimepirid Hexal
  • Belgium · Glimepiride Eg, Glimepiride Sandoz
  • Bulgaria · Амарил, Глимегамма, Glimegamma
  • Cyprus · Amaryl, Dia-Ban
  • Czechia · Glimepirid Sandoz, Glimepirid Viatris
  • Germany · Amaryl, Glimepirid 1 A Pharma
  • Denmark · Glimepirid "sandoz", Glimepirid Bluefish
  • Estonia · Amaryl, Glimepiride Accord
  • Spain · Amaryl, Glimepirida Alter
  • Finland · Oltar, Priglide
  • France · Amarel, Glimepiride Accord Healthcare
  • United Kingdom (Northern Ireland) · Glimepiride Accord Healthcare, Glimepiride Bristol Laboratories
  • Greece · Anovis, Dia-Ban
  • Croatia · Amaryl, Melpamid
  • Hungary · Glimepirid 1 A Pharma, Glimepirid Hexal
  • Iceland · Glimeryl
  • Italy · Amaryl, Glimepiride Accord Healthcare
  • Lithuania · Amaryl
  • Luxembourg · Glimepiride Eg
  • Latvia · Amaryl
  • Malta · Glimepiride Aurobindo
  • Netherlands · Amaryl, Fertin
  • Norway · Glimepirid Teva
  • Poland · Amaryl, Amaryl 1
  • Portugal · Glimepirida Aurovitas, Glimepirida Ciclum
  • Romania · Amaryl
  • Sweden · Glimepirid Actavis, Glimepirid Bluefish
  • Slovakia · Glimepirid Sandoz, Melyd

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/da1410d8-e587-4458-8e6d-081fe7e17245
GET /v1/drugs/da1410d8-e587-4458-8e6d-081fe7e17245?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "1",
  "substance": "GLIMEPIRIDE",
  "productndc": "60429-918",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA077911",
  "marketing_category": "ANDA"
}

See everything about glimepiride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.